Summary of results: Pain‐free and headache relief | |||||||
Baseline pain | Studies |
Attacks treated |
Treatment (%) |
Placebo or comparator (%) |
Risk ratio (95% CI) |
NNT (95% CI) |
|
Pain‐free at 2 h | |||||||
Sumatriptan plus naproxen 85/500 mg vs placebo | mild | 8 | 3395 | 50 | 18 | 2.8 (2.4 to 3.1) | 3.1 (2.9 to 3.5) |
Sumatriptan plus naproxen 50‐85/500 mg vs placebo | ≥ mod | 4 | 2596 | 28 | 7.7 | 3.7 (3.0 to 4.5) | 4.9 (4.3 to 5.7) |
Sumatriptan plus naproxen 85/500 mg vs placebo | ≥ mod | 3 | 2105 | 27 | 8.1 | 3.3 (2.6 to 4.1) | 5.4 (4.6 to 6.5) |
Sumatriptan plus naproxen 50‐85/500 mg vs sumatriptan 50‐85 mg | ≥ mod | 3 | 1925 | 32 | 23 | 1.4 (1.2 to 1.7) | 10 (7.4 to 18) |
Sumatriptan plus naproxen 50‐85/500 mg vs naproxen 500 mg | ≥ mod | 3 | 1944 | 32 | 16 | 2.0 (1.7 to 2.4) | 6.1 (5.0 to 7.9) |
Headache relief at 2 h | |||||||
Sumatriptan plus naproxen 50‐85/500 mg vs placebo | ≥ mod | 4 | 2596 | 58 | 27 | 2.2 (2.0 to 2.4) | 3.2 (2.9 to 3.6) |
Sumatriptan plus naproxen 85/500 mg vs placebo | ≥ mod | 3 | 2105 | 57 | 27 | 2.1 (1.9 to 2.4) | 3.4 (3.0 to 3.9) |
Sumatriptan plus naproxen 50‐85/500 mg vs sumatriptan 50‐85 mg | ≥ mod | 3 | 1925 | 62 | 52 | 1.2 (1.1 to 1.3) | 9.8 (6.8 to 17) |
Sumatriptan plus naproxen 50‐85/500 mg vs naproxen 500 mg | ≥ mod | 3 | 1944 | 62 | 44 | 1.4 (1.3 to 1.5) | 5.5 (4.4 to 7.2) |
Sustained pain‐free during the 24 h post dose | |||||||
Sumatriptan plus naproxen 85/500 mg vs placebo | mild | 8 | 3396 | 37 | 12 | 3.0 (2.6 to 3.6) | 4.1 (3.7 to 4.6) |
Sumatriptan plus naproxen 50‐85/500 mg vs placebo | ≥ mod | 4 | 2596 | 20 | 6 | 3.4 (2.7 to 4.4) | 7.0 (5.9 to 8.5) |
Sumatriptan plus naproxen 85/500 mg vs placebo | ≥ mod | 3 | 2005 | 19 | 6 | 3.1 (2.4 to 4.0) | 7.7 (6.4 to 9.8) |
Sumatriptan plus naproxen 50‐85/500 mg vs sumatriptan 50‐85 mg | ≥ mod | 3 | 1925 | 24 | 14 | 1.7 (1.4 to 2.1) | 10 (7.4 to 15) |
Sumatriptan plus naproxen 50‐85/500 mg vs naproxen 500 mg | ≥ mod | 3 | 1944 | 24 | 11 | 2.3 (1.8 to 2.8) | 7.4 (6.0 to 9.9) |
Sustained headache relief during the 24 h post dose | |||||||
Sumatriptan plus naproxen 50‐85/500 mg vs placebo | ≥ mod | 4 | 2596 | 43 | 16 | 2.6 (2.3 to 3.0) | 3.8 (3.4 to 4.3) |
Sumatriptan plus naproxen 85/500 mg vs placebo | ≥ mod | 3 | 2107 | 42 | 16 | 2.6 (2.2 to 3.0) | 3.9 (3.4 to 4.5) |
Sumatriptan plus naproxen 50‐85/500 mg vs sumatriptan 50‐85 mg | ≥ mod | 3 | 1925 | 46 | 33 | 1.4 (1.2 to 1.6) | 7.9 (5.9 to 12) |
Sumatriptan plus naproxen 50‐85/500 mg vs naproxen 500 mg | ≥ mod | 3 | 1944 | 46 | 28 | 1.6 (1.5 to 1.9) | 5.6 (4.5 to 7.4) |